Literature DB >> 6607211

Effects of tumour promoter phorbol myristate acetate on mouse lymphocytes: selective inhibition of B cell activation by mitogens and antigens.

C M Hawrylowicz, G G Klaus.   

Abstract

The effect of the tumour promoter phorbol myristate acetate (PMA) on the responses of mouse lymphocytes to various stimuli was studied in vitro. Nanomolar concentrations of PMA inhibited B cell proliferation induced by lipopolysaccharide and by anti-Ig antibodies, and the polyclonal antibody response to lipopolysaccharide. Specific antibody responses to both T-dependent and T-independent antigens were similarly affected. In marked contrast, T cell proliferation elicited by various mitogens was 10- to 1000-fold more resistant to inhibition. Cell fractionation experiments suggest that the effects on B cell responses are the results of a direct anti-proliferative effect of PMA on responding B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6607211      PMCID: PMC1454439     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  14 in total

1.  Phorbol diester receptor copurifies with protein kinase C.

Authors:  J E Niedel; L J Kuhn; G R Vandenbark
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

2.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

3.  Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D.

Authors:  S B Mizel; D L Rosenstreich; J J Oppenheim
Journal:  Cell Immunol       Date:  1978-09-15       Impact factor: 4.868

4.  Independent and synergistic thymocyte proliferative activities of PMA and IL 1.

Authors:  T Krakauer; D Mizel; J J Oppenheim
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

5.  Phorbol myristic acetate enhances the production of interleukin 2.

Authors:  J Fuller-Farrar; M L Hilfiker; W L Farrar; J J Farrar
Journal:  Cell Immunol       Date:  1981-02       Impact factor: 4.868

Review 6.  Tumor promoters and the mechanism of tumor promotion.

Authors:  L Diamond; T G O'Brien; W M Baird
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

7.  Concomitant enhancement of B-cell mitogenesis and inhibition of antibody synthesis by a phorbol ester.

Authors:  T A Ferguson; L A Fish; C S Baxter; J G Michael
Journal:  Proc Soc Exp Biol Med       Date:  1982-10

8.  Murine lymphocyte comitogenesis by phorbol esters, and its inhibition by retinoic acid and inhibitors of polyamine biosynthesis.

Authors:  L A Fish; C S Baxter; J A Bash
Journal:  Toxicol Appl Pharmacol       Date:  1981-03-30       Impact factor: 4.219

9.  Binding of [3H]12-O-tetradecanoylphorbol-13-acetate to intact human peripheral blood lymphocytes.

Authors:  R D Estensen; D K DeHoogh; C F Cole
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

10.  Thymoma production of T cell growth factor (Interleukin 2).

Authors:  J J Farrar; J Fuller-Farrar; P L Simon; M L Hilfiker; B M Stadler; W L Farrar
Journal:  J Immunol       Date:  1980-12       Impact factor: 5.422

View more
  5 in total

1.  Phorbol myristate acetate inhibits anti-IgM-mediated signaling in resting B cells.

Authors:  J Mizuguchi; M A Beaven; J H Li; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Activation and proliferation signals in mouse B cells. IV. Concanavalin A stimulates B cells to leave G0, but not to proliferate.

Authors:  C M Hawrylowicz; G G Klaus
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

3.  Activation and proliferation signals in mouse B cells. IX. Protein kinase C activators synergize with non-mitogenic anti-immunoglobulin antibodies to drive B cells into G1.

Authors:  M K Bijsterbosch; J B McLaughlin; M Holman; G G Klaus
Journal:  Immunology       Date:  1988-05       Impact factor: 7.397

4.  Crosslinking of surface immunoglobulin and Fc receptors on B lymphocytes inhibits stimulation of inositol phospholipid breakdown via the antigen receptors.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307

5.  Lymphoma models for B cell activation and tolerance. III. Cell cycle dependence for negative signalling of WEHI-231 B lymphoma cells by anti-mu.

Authors:  D W Scott; D Livnat; C A Pennell; P Keng
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.